Cargando…
The COVID-19 risk in the cross-section of equity options
We use the implied volatility slope measures derived from US stock options to examine the impact of COVID-19 risk on the options market. The severity of COVID-19 is measured by the number of new confirmed cases. We find that equity options that are most sensitive to COVID-19 generate a more positive...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908572/ https://www.ncbi.nlm.nih.gov/pubmed/36785797 http://dx.doi.org/10.1016/j.frl.2023.103684 |
_version_ | 1784884391616446464 |
---|---|
author | Jitsawatpaiboon, Kanokrak Ruan, Xinfeng |
author_facet | Jitsawatpaiboon, Kanokrak Ruan, Xinfeng |
author_sort | Jitsawatpaiboon, Kanokrak |
collection | PubMed |
description | We use the implied volatility slope measures derived from US stock options to examine the impact of COVID-19 risk on the options market. The severity of COVID-19 is measured by the number of new confirmed cases. We find that equity options that are most sensitive to COVID-19 generate a more positive IV slope than less COVID-19-sensitive equity options. Moreover, this measure is more positive and significant during the lockdown period. Our findings suggest that the hedging cost of downside tail risk is more expensive during the high-uncertainty period, the time when COVID-19 is more intensive. |
format | Online Article Text |
id | pubmed-9908572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author(s). Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99085722023-02-09 The COVID-19 risk in the cross-section of equity options Jitsawatpaiboon, Kanokrak Ruan, Xinfeng Financ Res Lett Article We use the implied volatility slope measures derived from US stock options to examine the impact of COVID-19 risk on the options market. The severity of COVID-19 is measured by the number of new confirmed cases. We find that equity options that are most sensitive to COVID-19 generate a more positive IV slope than less COVID-19-sensitive equity options. Moreover, this measure is more positive and significant during the lockdown period. Our findings suggest that the hedging cost of downside tail risk is more expensive during the high-uncertainty period, the time when COVID-19 is more intensive. The Author(s). Published by Elsevier Inc. 2023-05 2023-02-09 /pmc/articles/PMC9908572/ /pubmed/36785797 http://dx.doi.org/10.1016/j.frl.2023.103684 Text en © 2023 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Jitsawatpaiboon, Kanokrak Ruan, Xinfeng The COVID-19 risk in the cross-section of equity options |
title | The COVID-19 risk in the cross-section of equity options |
title_full | The COVID-19 risk in the cross-section of equity options |
title_fullStr | The COVID-19 risk in the cross-section of equity options |
title_full_unstemmed | The COVID-19 risk in the cross-section of equity options |
title_short | The COVID-19 risk in the cross-section of equity options |
title_sort | covid-19 risk in the cross-section of equity options |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908572/ https://www.ncbi.nlm.nih.gov/pubmed/36785797 http://dx.doi.org/10.1016/j.frl.2023.103684 |
work_keys_str_mv | AT jitsawatpaiboonkanokrak thecovid19riskinthecrosssectionofequityoptions AT ruanxinfeng thecovid19riskinthecrosssectionofequityoptions AT jitsawatpaiboonkanokrak covid19riskinthecrosssectionofequityoptions AT ruanxinfeng covid19riskinthecrosssectionofequityoptions |